These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8483812)
1. Peptidases and smooth muscle cell angiotensin II receptor pharmacology. Cohen RB; Webb ML; Dickinson KE Peptides; 1993; 14(2):345-52. PubMed ID: 8483812 [TBL] [Abstract][Full Text] [Related]
2. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta. Fujimoto M; Mihara S; Shigeri Y; Itazaki K Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989 [TBL] [Abstract][Full Text] [Related]
3. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues. Pendleton RG; Gessner G; Horner E J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998 [TBL] [Abstract][Full Text] [Related]
5. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat. Harding JW; Yoshida MS; Dilts RP; Woods TM; Wright JW J Neurochem; 1986 Apr; 46(4):1292-7. PubMed ID: 3950629 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of angiotensin II type II receptors in rat pheochromocytoma cells. Webb ML; Liu EC; Cohen RB; Hedberg A; Bogosian EA; Monshizadegan H; Molloy C; Serafino R; Moreland S; Murphy TJ Peptides; 1992; 13(3):499-508. PubMed ID: 1326103 [TBL] [Abstract][Full Text] [Related]
7. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. Abhold RH; Sullivan MJ; Wright JW; Harding JW J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120 [TBL] [Abstract][Full Text] [Related]
8. Characterization of angiotensin-II receptor subtype on bovine thecal cells and its regulation by luteinizing hormone. Brunswig-Spickenheier B; Mukhopadhyay AK Endocrinology; 1992 Sep; 131(3):1445-52. PubMed ID: 1505474 [TBL] [Abstract][Full Text] [Related]
9. Are angiotensin receptors in vascular smooth muscles a homogeneous population? Tabrizchi R; Pang CC Eur J Pharmacol; 1987 Oct; 142(3):359-66. PubMed ID: 3428350 [TBL] [Abstract][Full Text] [Related]
10. Is the adrenal angiotensin receptor angiotensin II--or angiotensin III like? Braley LM; Menachery AI; Underwood RH; Williams GH Acta Endocrinol (Copenh); 1983 Jan; 102(1):116-21. PubMed ID: 6297210 [TBL] [Abstract][Full Text] [Related]
11. Human aortic smooth muscle cells containing angiotensin II type 1 receptors. Yazawa H; Iida-Kubota E; Honda K Jpn J Pharmacol; 1993 Aug; 62(4):339-43. PubMed ID: 8230860 [TBL] [Abstract][Full Text] [Related]
12. Characterization of angiotensin receptors on bovine adrenal fasciculata cells. Vallotton MB; Capponi AM; Grillet C; Knupfer AL; Hepp R; Khosla MC; Bumpus FM Proc Natl Acad Sci U S A; 1981 Jan; 78(1):592-6. PubMed ID: 6264451 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the binding and functional actions of angiotensin agonists in clone 9 cells: additional evidence for angiotensin II receptor heterogeneity. Kozlowski MR; Arcuri M; Zynardi L J Recept Res; 1993; 13(7):1031-40. PubMed ID: 8396180 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells. Briand V; Riva L; Galzin AM Br J Pharmacol; 1994 Aug; 112(4):1195-201. PubMed ID: 7952881 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin I, II, and II tachyphylaxis in the mesenteric vascular circuit of the rat. Fasciolo JC; Binia A Hypertension; 1981; 3(6 Pt 2):II-166-70. PubMed ID: 7028614 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist. Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838 [TBL] [Abstract][Full Text] [Related]
17. Receptor binding and internalization of a unique biologically active angiotensin II-colloidal gold conjugate: morphological analysis of angiotensin II processing in isolated vascular strips. Anderson KM; Peach MJ J Vasc Res; 1994; 31(1):10-7. PubMed ID: 7903871 [TBL] [Abstract][Full Text] [Related]
18. Identification of selective, high affinity [125I]-angiotensin and [125I]-bradykinin binding sites in rat intestinal epithelia. Cox HM; Munday KA; Poat JA Br J Pharmacol; 1986 Jan; 87(1):201-9. PubMed ID: 2869810 [TBL] [Abstract][Full Text] [Related]
20. Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. Ullian ME; Linas SL J Clin Invest; 1989 Sep; 84(3):840-6. PubMed ID: 2760215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]